Alimera Sciences Inc.

NASDAQ: ALIM · Real-Time Price · USD
5.54
-0.01 (-0.18%)
At close: Sep 13, 2024, 10:00 PM

Alimera Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
80.75M 54.13M 59.03M
Cost of Revenue
19.58M 7.98M 7.03M
Gross Profit
61.17M 46.15M 52M
Operating Income
-1.93M -11.64M -201K
Interest Income
n/a n/a n/a
Pretax Income
-20.05M -18.08M -3.93M
Net Income
-20.13M -18.11M -4.37M
Selling & General & Admin
46.02M 38.86M 35.84M
Research & Development
16.63M 16.23M 13.78M
Other Expenses
n/a 2.71M 2.58M
Operating Expenses
62.64M 57.79M 52.2M
Interest Expense
10.19M 5.88M 5.41M
Selling & Marketing Expenses
27.95M 25.99M 23.07M
Cost & Expenses
73.94M 65.77M 52.2M
Income Tax Expense
85K 28K 438K
Shares Outstanding (Basic)
25.56M 7M 6.59M
Shares Outstanding (Diluted)
25.56M 7M 6.59M
EPS (Basic)
-0.79 -2.59 -0.66
EPS (Diluted)
-0.79 -2.59 -0.66
EBITDA
-1.11M -8.93M 2.38M
EBIT
-9.86M -12.2M 1.48M
Depreciation & Amortization
8.75M 2.71M 2.58M